DuPont is executing a rapid commercialization strategy in its Applied BioSciences business for a diverse portfolio of high-performance, renewable products that address the needs of large markets. Thee company has set goals for the Applied BioSciences business of US$1 billion in revenue and US$250 million in pretax earnings by 2015.
For more details on Growing demand drives global commercialization for DuPont Renewable Products click here
No comments:
Post a Comment